Back to companies

Aimmune Therapeutics Inc: Overview

Want to continue viewing company data?

Sign up for exclusive competitve intelligence.

Create account

Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company. It develops proprietary product candidates for the treatment of peanut and other food allergies. Aimmune's product pipeline includes AR101- Peanut Allergy Powder-dnfp (PALFORZIA), used to treat the peanut allergy. Its pipeline program portfolio uses characterized oral desensitization immunotherapy (CODIT), a proprietary approach to oral immunotherapy. In addition, Aimmune also discovers, develops and commercializes therapies related to food allergy. The company conducts academic research in partnership with various universities and other companies to develop novel product candidates. The company operates in the US and the UK. Aimmune is headquartered in Brisbane, California, the US.

Headquarters United States of America

Address Suite 300, 8000 Marina Blvd., Brisbane, California, 94005-1884


No of Employees 261

Industry Pharmaceuticals and Healthcare

Products and Services

Products
Pipeline
AR101- Peanut Allergy Powder-dnfp (PALFORZIA)
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2020 Contracts/Agreements In August, the company entered into an agreement to be acquired by Nestle Health Science for US$2.6 billion.
2020 Financing Agreements In February, the company announced to secure US$200 million funding from Nestle Health Science.
2018 Ownership Changes In November, Nestle Health Science increased its equity stake in the company to 19% stake.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Aimmune Therapeutics Inc Exelixis Inc Globeimmune Inc Soligenix Inc Array BioPharma Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Brisbane Alameda Louisville Princeton Boulder
State/Province California California Colorado New Jersey Colorado
No. of Employees 261 773 22 17 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Mark McDade Chairman Executive Board 2015 64
Jayson Dallas, M.D. Director; Chief Executive Officer; President Senior Management 2018 52
Eric Bjerkholt Chief Financial Officer Senior Management 2017 60
Daniel C. Adelman, M.D. Chief Medical Officer Senior Management 2016 62
Andrew Oxtoby Chief Commercial Officer Senior Management 2019 46
Non Dignissim Eros Proin vel Convallis 2021 XX
Non Dignissim Eros Proin vel Convallis 2021 XX
Non Dignissim Eros Proin vel Convallis 2021 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe